Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data (Q33366370)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data |
scientific article |
Statements
1 reference
Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data (English)
1 reference
Russell Vang
1 reference
Ie-Ming Shih
1 reference
Ritu Salani
1 reference
Elizabeth Sugar
1 reference
Robert J Kurman
1 reference
1 November 2008
1 reference
1 reference
Identifiers
1 reference